Science Explorer Back to mapMap
Discussion
Company · San Sebastian · Spain

KUSUDAMA Therapeutics (Spain)

kusudama.euROR OpenAlex
Research works
1
▼ 79% vs 2018-21
Citations
14
17.3 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
62%
world 40%
International
100%
world 18%
KUSUDAMA Therapeutics (Spain)

Not ranked overall: KUSUDAMA Therapeutics (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does KUSUDAMA Therapeutics (Spain) work in?

In all years, 56% of research at KUSUDAMA Therapeutics (Spain) is in Health Sciences, 44% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (22%), Agricultural and Biological Sciences (11%).

Health Sciences: 0 fractional works · 55.6% of its workMedicine: 0 fractional works · 55.6% of its workLife Sciences: 0 fractional works · 44.4% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 22.2% of its workAgricultural and Biological Sciences: 0 fractional works · 11.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 11.1% of its workALL ITS WORKKUSUDAMATherapeutics…1fractional works, all years
Life Sciences44%Health Sciences56%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 4 fields, with their numbers
    1. Medicine055.6%
    1. Biochemistry, Genetics and Molecular Biology022.2%
    2. Agricultural and Biological Sciences011.1%
    3. Pharmacology, Toxicology and Pharmaceutics011.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from KUSUDAMA Therapeutics (Spain)?

The most cited paper from KUSUDAMA Therapeutics (Spain) is "Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections" (Duy‐Khiet Ho, Xabier Murgia, Chiara Rossi et al., 2020), with 58 citations. Next come "Micro-rheological properties of lung homogenates correlate with infection severity in a mouse model of Pseudomonas aeruginosa lung infection" (21) and "Self-Assembled Amphiphilic Starch Based Drug Delivery Platform: Synthesis, Preparation, and Interactions with Biological Barriers" (20).

Most cited papers
#PaperReleasedCitations
1 Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections Duy‐Khiet Ho, Xabier Murgia, Chiara Rossi et al. · Angewandte Chemie International Edition Open access 3 Apr 2020 58
2 Micro-rheological properties of lung homogenates correlate with infection severity in a mouse model of Pseudomonas aeruginosa lung infection Xabier Murgia, Andreas M. Kany, Christian Herr et al. · Scientific Reports Open access 5 Oct 2020 21
3 Self-Assembled Amphiphilic Starch Based Drug Delivery Platform: Synthesis, Preparation, and Interactions with Biological Barriers V.H. Giang Phan, Huu Thuy Trang Duong, Phu‐Tri Tran et al. · Biomacromolecules 21 Dec 2020 20
4 Tobramycin nanoformulation for chronic pulmonary infections: From drug product definition to scale-up for preclinical evaluation Julie Movellan, Xabier Murgia, Raquel Gracia et al. · International Journal of Pharmaceutics Open access 23 Jan 2025 5
5 Cover Picture: Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections (Angew. Chem. Int. Ed. 26/2020) Duy‐Khiet Ho, Xabier Murgia, Chiara Rossi et al. · Angewandte Chemie International Edition 28 Apr 2020 1
All 6 most cited papers, with filters and sorting

Which research topics does KUSUDAMA Therapeutics (Spain) publish most on?

By volume in 2022-now: Antimicrobial Peptides and Activities, Inhalation and Respiratory Drug Delivery and Pneumonia and Respiratory Infections.

  1. 1 Antimicrobial Peptides and Activities Microbiology 0 works
  2. 2 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
  3. 3 Pneumonia and Respiratory Infections Epidemiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available61.8%not open38.2%

World: 40% of research is openly available.

with international co-authors100.0%

World: 18% is written across borders.

Other research institutions in San Sebastian

All research institutions in San Sebastian

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about KUSUDAMA Therapeutics (Spain). Posts are plain text and can be reported.